Cargando…
Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761(®))
Mild cognitive impairment (MCI) and dementia are clinically prevalent in the elderly. There is a high risk of cognitive decline in patients diagnosed with MCI or dementia. This review describes the effectiveness of Ginkgo biloba leaf special extract EGb 761(®) for the treatment of dementia syndromes...
Autores principales: | Tomino, Carlo, Ilari, Sara, Solfrizzi, Vincenzo, Malafoglia, Valentina, Zilio, Guglielmo, Russo, Patrizia, Proietti, Stefania, Marcolongo, Federica, Scapagnini, Giovanni, Muscoli, Carolina, Rossini, Paolo Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065464/ https://www.ncbi.nlm.nih.gov/pubmed/33915701 http://dx.doi.org/10.3390/ph14040305 |
Ejemplares similares
-
Ginkgo biloba extract EGb 761(®) in the symptomatic treatment of mild-to-moderate dementia: a profile of its use
por: McKeage, Kate, et al.
Publicado: (2018) -
The Effect of Ginkgo Biloba (EGb 761) on Epileptic Activity in Rabbits
por: Ivetic, Vesna, et al.
Publicado: (2008) -
Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review
por: Hort, Jakub, et al.
Publicado: (2023) -
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761(®)
por: Kandiah, Nagaendran, et al.
Publicado: (2019) -
Strategies for the use of Ginkgo biloba extract, EGb 761(®), in the treatment and management of mild cognitive impairment in Asia: Expert consensus
por: Kandiah, Nagaendran, et al.
Publicado: (2020)